
REPRESSIT year meeting 2025
2025-02-17
Meet the professor 2025
2025-03-25
REPRESSIT year meeting 2025
2025-02-17
Meet the professor 2025
2025-03-25Check-PAINT
Immune-mediated inflammatory diseases (IMIDs) affect 5–7% of the Western population. IMIDs comprise a chronic, clinically diverse group of conditions and many patients still lack good treatment options. Stimulation of immune checkpoint receptors is a novel strategy to suppress inflammation in IMIDs. Development of therapeutic checkpoint stimulators to suppress inflammation is challenging. In contrast to most receptors, scientists do not understand how the concentration or binding strength of natural stimulators affects these checkpoints.
With a recently developed microscopy technique and a unique set of checkpoint receptor binders, we will study the detailed characteristics of binder:receptor interaction that determine immune checkpoint function. With this knowledge, we aim to chemically synthesise checkpoint stimulators for future therapeutic use in inflammatory disease.























